Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.10.16
-
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR PHASE IB/II CLINICAL TRIAL OF INNOVATIVE DRUG "GMA106 (GIPR ANTAGONIST/GLP-1R AGONIST)" ACCEPTED BY CDE2023.10.16
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.10.13
-
VOLUNTARY ANNOUNCEMENT - DISPOSAL OF EQUITY INTEREST IN CT TONGYONG2023.10.10
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.10.10
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.10.06
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.10.05
-
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 20232023.10.04